IPDA for High-Priority HIV-1 Subtypes to Enable Global Eradication Trials
Awarded Award Notice Posted
- Solicitation number
- PHS-2020-1
- Agency
- National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
- Awarded
- to Accelevir Diagnostics LLC
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N93020C00015 Federal contract award
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- Not on record
Notice details come from SAM.gov. Updated .
About this opportunity
AcceleVir Diagnostics, LLC was awarded a one-year, $299,975 contract by the National Institute of Allergy and Infectious Diseases to conduct research on high-priority HIV-1 subtypes that are important to global clinical trials aimed at potentially eradicating HIV/AIDS worldwide. The contract number 75N93020C00015 was awarded on September 25, 2020 to facilitate the contractor's work on HIV-1 subtypes to enable these global clinical research efforts.
Notice text
Awarded contract 75N93020C00015 to ACCELEVIR DIAGNOSTICS, LLC for 299975.00 on 2020-06-01.
Notice history
| Notice | Type | Posted |
|---|---|---|
| IPDA for High-Priority HIV-1 Subtypes to Enable Global Eradication Trials | Award Notice | |
| Novel Nanoparticle-in-Hydrogel Co-Delivery of Adjuvanted saRNA as HIV Vaccine | Award Notice | |
| A Nanovaccine for Eliciting Broadly Neutralizing Antibodies Against HIV-1 | Award Notice | |
| Vaccines Enabling HIV Prevention Targeting Germinal Center Enhancement with Engineered Slow Release Nanoparticles | Award Notice | |
| A solicitation of the national institutes of health (NIH) and the centers for disease control and prevention (CDC) for small business innovation research (sbir) contract proposals | Solicitation |
And 2 more award notices.
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity